Key result
Discontinuation of angiotensin-converting enzyme inhibitors or beta-blockers was the most important risk factor for increased hospitalization rates among 254 heart failure patients.
Why the study?
Medication adherence is poor in heart failure, and electronic monitoring-based adherence analyses usually do not consider the decomposed stages of adherence including initiation, implementation, and discontinuation.
Does discontinuation of ACE inhibitors or beta-blockers increase hospitalization rates in adults with chronic heart failure?
Cohort (n=254)
Does discontinuation of ACE inhibitors or beta-blockers increase hospitalization rates in adults with chronic heart failure?
Discontinuation of ACE inhibitors or beta-blockers is a major risk factor for increased hospitalization in patients with chronic heart failure, highlighting the critical need for adherence interventions.
May warrant adherence interventions for ACE inhibitors and beta-blockers in heart failure; hypothesis-generating and requires randomized confirmation.
BACKGROUND: Adherence to evidence-based therapy is essential for optimal management of heart failure. Yet, medication adherence is poor in heart failure patients. The Ascertaining Barriers to Compliance Project decomposed the medication adherence process into initiation, implementation, and discontinuation stages, but electronic monitoring-based adherence analyses usually do not consider this process. AIMS: The aim of this study was to describe individual-patient patterns of medication adherence from electronic monitoring data among adults with chronic heart failure, adherence types, and risk factors for increased all-cause hospitalization including measures of poor adherence such as discontinuation. METHODS: Data from two prospective studies of adherence measured with electronic monitoring for heart failure patients were combined and restricted to monitoring of angiotensin-converting enzyme inhibitors and beta-blockers over an initial three-month period. Hospitalizations were recorded for this period as well as for a three-month follow-up period. Analyses were conducted using adaptive modeling methods to identify individual-patient adherence patterns, adherence types, and risk factors for an increased hospitalization rate. RESULTS: Using electronic monitoring data for 254 heart failure patients, four adherence types were identified: highly consistent, consistent but variable, moderately consistent, and poorly consistent. Sixteen individually significant risk factors for increased hospitalization rates were identified and used to generate a multiple risk factors model. Medication discontinuation was the most important individual risk factor and most important in the multiple risk factors model. CONCLUSION: Discontinuation of angiotensin-converting enzyme inhibitors or beta-blockers increases hospitalization rates for heart failure patients. Interventions that effectively address this problem are urgently needed.
No takes yet. Share an insight, caveat, or question.
Knafl et al. (2019) conducted a cohort in chronic heart failure (n=254). Discontinuation of angiotensin-converting enzyme inhibitors or beta-blockers was evaluated on hospitalization rates. Discontinuation of angiotensin-converting enzyme inhibitors or beta-blockers was the most important risk factor for increased hospitalization rates among 254 heart failure patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: